Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Because gallbladder cancer is rare, it's been hard to study. Most experts agree that treatment in a clinical trial should be considered for people with any stage of gallbladder cancer.
Gallbladder cancer research is being done in many university hospitals, medical centers, and other institutions around the world. Each year, scientists learn more about what causes the disease, how to prevent it, and how better to treat it. The new and promising treatments discussed here might be available only in clinical trials.
Because gallbladder cancer is often found after surgery to remove the gallbladder for other problems (like gallstones), doctors are looking for ways to know whether gallbladder problems are being caused by cancer before surgery is done. For instance, studies are looking at how better to use imaging tests, like MRI and CT scans, to more accurately identify and diagnose changes in the gallbladder.
Identifying proteins that are linked to gallbladder inflammation is another area of research. Early research has suggested that high blood levels of certain proteins may help show which people have gallstones and which have cancer. This could even be used as a screening test in the future, but a lot more research is needed.
Researchers are looking for better ways to use radiation therapy, as well as how best to use it with other treatments, like surgery and chemotherapy. Using certain chemo drugs and radiation together has been found to work better than either treatment alone. This is called chemoradiation. Research is looking at the timing of these treatments, as well as learning which drugs work best with radiation to treat gallbladder cancer.
Chemotherapy has had limited effect against gallbladder cancer, but new drugs and drug combinations are being tested. Studies are also looking for better ways to combine chemo and other treatments, like surgery and radiation.
There's a lot of research on combining chemotherapy and targeted therapy.
Many drugs that target a specific change (mutation) in cancer cells have been approved by the U.S. Food and Drug Administration (FDA) and are used today. These include drugs that target mutations, including NTRK, RET, BRAF, FGFR2, IDH1, RET, KRAS, and HER2. Studies also are looking at other targetable mutations.
Another area of active research is how combining targeted therapy with other treatments, such as chemotherapy, can better help kill gallbladder cancer cells. Different drug combinations are being tested in clinical trials for use in treating gallbladder cancer.
Immunotherapy is designed to boost the body’s natural defenses to fight the cancer. Current clinical trials are testing different immunotherapy drugs to treat gallbladder cancer.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Juengpanich S, Li S, Yang T, Xie T, Chen J, Shan Y,et al . Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancer. Nat Commun. 2023 Sep 14;14(1):5699. doi: 10.1038/s41467-023-41389-1.
Kam AE, Masood A, Shroff RT. Current and emerging therapies for advanced biliary tract cancers. Lancet Gastroenterol Hepatol. 2021 Nov;6(11):956-969. doi: 10.1016/S2468-1253(21)00171-0.
Montalvo-Jave EE, Rahnemai-Azar AA, Papaconstantinou D, Deloiza ME, Tsilimigras DI, Moris D, Mendoza-Barrera GE, Weber SM, Pawlik TM. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review. Surg Oncol. 2019 Dec;31:83-89. doi: 10.1016/j.suronc.2019.09.006. Epub 2019 Sep 13. PMID: 31541911.
Zhou Y, Yuan K, Yang Y, Ji Z, Zhou D, Ouyang J, et al. Gallbladder cancer: current and future treatment options. Front Pharmacol. 2023 May 11;14:1183619. doi: 10.3389/fphar.2023.1183619. PMID: 37251319; PMCID: PMC10213899.
Last Revised: May 16, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.